BETA

THE SILVERSTEIN FOUNDATION FOR GBA RESEARCH: Form 990, tax year 2020

View the entire original 990 at ProPublica ↗

Organization
THE SILVERSTEIN FOUNDATION FOR GBA RESEARCH (EIN 82-0656623)
Tax period
2020-01-01 to 2020-12-31
Filed
2021-10-01
IRS object ID
202142749349301014
Schema version
2020v4.1
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2021-10-01T16:27:20-05:00ReturnTs
Tax Period End2020-12-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

FieldValueIRS element (for citing)
Preparer Firm EIN135565207PreparerFirmEIN

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1KPMG LLPBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line1345 PARK AVENUEAddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP101540102ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2020-01-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN820656623EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1THE SILVERSTEIN FOUNDATION FORBusinessNameLine1Txt
Business Name Line2PARKINSON'S WITH GBABusinessNameLine2Txt
FieldValueIRS element (for citing)
Business Name ControlSILVBusinessNameControlTxt
Phone9175198108PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1PO BOX 237137AddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10023ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonNATALIE SILVERSTEINPersonNm
Person TitleVICE PRES/TREASURERPersonTitleTxt
Phone9175198108PhoneNum
Signature2021-10-01SignatureDt
Discuss With Paid PreparerYes (1)DiscussWithPaidPreparerInd

Signing Officer SigningOfficerGrp

Person Full Name PersonFullName

FieldValueIRS element (for citing)
Person FirstNATALIEPersonFirstNm
Person LastSILVERSTEINPersonLastNm
FieldValueIRS element (for citing)
SSN999009999SSN

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonDAVID M HIGHFILLPreparerPersonNm
PTINP01517891PTIN
Phone2127589700PhoneNum
Preparation2021-10-01PreparationDt

Additional Filer Information AdditionalFilerInformation

Trusted Customer TrustedCustomerGrp

FieldValueIRS element (for citing)
Trusted Customer3TrustedCustomerCd
Authentication Assurance LevelAAL1AuthenticationAssuranceLevelCd
Identity Assurance LevelIAL1IdentityAssuranceLevelCd
FieldValueIRS element (for citing)
Tax2020TaxYr
Build TS2022-09-23 18:48:47ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Principal OfficerJONATHAN SILVERSTEINPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line1PO BOX 237137AddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10023ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$74,303GrossReceiptsAmt
Group Return For Affiliates0GroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website AddressWWW.SILVERSTEINFOUNDATION.ORGWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation2017FormationYr
Legal Domicile StateNYLegalDomicileStateCd
Activity Or MissionTO RAISE AWARENESS AROUND PARKINSON'S DISEASE ASSOCIATED WITH GBA MUTATIONS AND RELEVANT CLINICAL TRIALS FOR MUTATION CARRIERS. SEE ALSO PART III AND SCHEDULE O.ActivityOrMissionDesc
Voting Members Governing Body3VotingMembersGoverningBodyCnt
Voting Members Independent3VotingMembersIndependentCnt
Total Employee0TotalEmployeeCnt
Total Volunteers3TotalVolunteersCnt
Total Gross UBI$0TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$0NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$379,686PYContributionsGrantsAmt
CY Contributions Grants$67,317CYContributionsGrantsAmt
PY Program Service Revenue$0PYProgramServiceRevenueAmt
CY Program Service Revenue$0CYProgramServiceRevenueAmt
PY Investment Income$51,242PYInvestmentIncomeAmt
CY Investment Income$6,986CYInvestmentIncomeAmt
PY Other Revenue$0PYOtherRevenueAmt
CY Other Revenue$0CYOtherRevenueAmt
PY Total Revenue$430,928PYTotalRevenueAmt
CY Total Revenue$74,303CYTotalRevenueAmt
PY Grants And Similar Paid$848,201PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$626,701CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$0PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$0CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$0PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$0CYTotalFundraisingExpenseAmt
PY Other Expenses$57,099PYOtherExpensesAmt
CY Other Expenses$69,221CYOtherExpensesAmt
PY Total Expenses$905,300PYTotalExpensesAmt
CY Total Expenses$695,922CYTotalExpensesAmt
PY Revenues Less Expenses-$474,372PYRevenuesLessExpensesAmt
CY Revenues Less Expenses-$621,619CYRevenuesLessExpensesAmt
Total Assets BOY$3,351,322TotalAssetsBOYAmt
Total Assets EOY$3,115,597TotalAssetsEOYAmt
Total Liabilities BOY$16,925TotalLiabilitiesBOYAmt
Total Liabilities EOY$35,575TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$3,334,397NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$3,080,022NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionTHE SILVERSTEIN FOUNDATION FOR PARKINSON'S WITH GBA RESEARCH RAISES AWARENESS AROUND PARKINSON'S DISEASE ASSOCIATED WITH GBA MUTATIONS. SEE SCHEDULE O FOR MORE INFORMATION.MissionDesc
Significant New Program Srvc0SignificantNewProgramSrvcInd
Significant Change0SignificantChangeInd
Expense$626,701ExpenseAmt
Grant$626,701GrantAmt
DescSINCE THE LAUNCH OF THE SILVERSTEIN FOUNDATION IN MARCH OF 2017, IT HAS FUNDED OVER 30 GRANTS, RECEIVED DONATIONS FROM OVER 1000 DONORS AND SUPPORTED 7 DIFFERENT THERAPEUTIC APPROACHES, INCLUDING AUTOPHAGY, ANTISENSE OLIGONUCLEOTIDES, GENE THERAPY, ALPHA SYNUCLEIN DEGRADERS, GLUCOCEREBROSIDASE ACTIVATORS, SUBSTRATE REDUCTION THERAPY, AND AUTOLOGOUS INDUCED PLURIPOTENT STEM CELLS TO ACCELERATE RESEARCH AND CLINICAL TRIALS TO BRING NEW THERAPEUTIC OPTIONS TO PATIENTS. SEE SCHEDULE O.Desc
Total Program Service Expenses$626,701TotalProgramServiceExpensesAmt
Described In Section501c3Yes (1)DescribedInSection501c3Ind
Schedule B RequiredYes (1)ScheduleBRequiredInd
Political Campaign Acty0PoliticalCampaignActyInd
Lobbying Activities0LobbyingActivitiesInd
Subject To Proxy Tax0SubjectToProxyTaxInd
Donor Advised Fund0DonorAdvisedFundInd
Conservation Easements0ConservationEasementsInd
Collections Of Art0CollectionsOfArtInd
Credit Counseling0CreditCounselingInd
Donor Rstr Or Quasi Endowments0DonorRstrOrQuasiEndowmentsInd
Report Land Building Equipment0ReportLandBuildingEquipmentInd
Report Investments Other SecYes (1)ReportInvestmentsOtherSecInd
Report Program Related Invst0ReportProgramRelatedInvstInd
Report Other Assets0ReportOtherAssetsInd
Report Other Liabilities0ReportOtherLiabilitiesInd
Include FIN48 Footnote0IncludeFIN48FootnoteInd
Independent Audit Fincl StmtYes (1)IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt0ConsolidatedAuditFinclStmtInd
School Operating0SchoolOperatingInd
Foreign Office0ForeignOfficeInd
Foreign Activities0ForeignActivitiesInd
More Than5000 K To Org0MoreThan5000KToOrgInd
More Than5000 K To Individuals0MoreThan5000KToIndividualsInd
Professional Fundraising0ProfessionalFundraisingInd
Fundraising Activities0FundraisingActivitiesInd
Gaming Activities0GamingActivitiesInd
Operate Hospital0OperateHospitalInd
Grants To OrganizationsYes (1)GrantsToOrganizationsInd
Grants To Individuals0GrantsToIndividualsInd
Schedule J Required0ScheduleJRequiredInd
Tax Exempt Bonds0TaxExemptBondsInd
Engaged In Excess Benefit Trans0EngagedInExcessBenefitTransInd
PY Excess Benefit Trans0PYExcessBenefitTransInd
Loan Outstanding0LoanOutstandingInd
Grant To Related Person0GrantToRelatedPersonInd
Business Rln With Org Mem0BusinessRlnWithOrgMemInd
Business Rln With Fam Mem0BusinessRlnWithFamMemInd
Business Rln With35 Ctrl Ent0BusinessRlnWith35CtrlEntInd
Deductible Non Cash Contri0DeductibleNonCashContriInd
Deductible Art Contribution0DeductibleArtContributionInd
Terminate Operations0TerminateOperationsInd
Partial Liquidation0PartialLiquidationInd
Disregarded Entity0DisregardedEntityInd
Related Entity0RelatedEntityInd
Related Organization Ctrl Ent0RelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org0TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp0ActivitiesConductedPrtshpInd
Schedule O RequiredYes (1)ScheduleORequiredInd
IRP Document2IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Employee0EmployeeCnt
Unrelated Bus Incm Over Limit0UnrelatedBusIncmOverLimitInd
Foreign Financial Account0ForeignFinancialAccountInd
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTransInd
Taxable Party Notification0TaxablePartyNotificationInd
Nondeductible Contributions0NondeductibleContributionsInd
Quid Pro Quo Contributions0QuidProQuoContributionsInd
Rcv Fnds To Pay Prsnl Bnft Cntrct0RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct0PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services0IndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht Pymt0SubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst Inc0SubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members3GoverningBodyVotingMembersCnt
Independent Voting Member3IndependentVotingMemberCnt
Family Or Business RlnYes (1)FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties0DelegationOfMgmtDutiesInd
Change To Org Documents0ChangeToOrgDocumentsInd
Material Diversion Or Misuse0MaterialDiversionOrMisuseInd
Members Or Stockholders0MembersOrStockholdersInd
Election Of Board Members0ElectionOfBoardMembersInd
Decisions Subject To Approva0DecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (1)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (1)MinutesOfCommitteesInd
Officer Mailing Address0OfficerMailingAddressInd
Local Chapters0LocalChaptersInd
Form990 Provided To Gvrn BodyYes (1)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (1)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (1)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (1)RegularMonitoringEnfrcInd
Whistleblower Policy0WhistleblowerPolicyInd
Document Retention Policy0DocumentRetentionPolicyInd
Compensation Process CEO0CompensationProcessCEOInd
Compensation Process Other0CompensationProcessOtherInd
Investment In Joint Venture0InvestmentInJointVentureInd
States Where Copy Of Return Is FldNYStatesWhereCopyOfReturnIsFldCd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1JONATHAN T SILVERSTEINBusinessNameLine1Txt
FieldValueIRS element (for citing)
Phone9175198108PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line111 RIVERSIDE DRIVE APT PH-W2AddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10023ZIPCd
FieldValueIRS element (for citing)
No Listed Persons CompensatedYes (X)NoListedPersonsCompensatedInd

Form990 Part VII Section A Form990PartVIISectionAGrp (3 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtAverage Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmt
JONATHAN SILVERSTEIN
PRESIDENT / SECRETARY2.000.00Yes (X)Yes (X)$0$0$0
NATALIE SILVERSTEIN
VICE PRESIDENT / TREASURER1.000.00Yes (X)Yes (X)$0$0$0
GEOFFREY LEVIN
BOARD MEMBER1.000.00Yes (X)$0$0$0
FieldValueIRS element (for citing)
Total Reportable Comp From Org$0TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$0TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K0IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed0FormerOfcrEmployeesListedInd
Total Comp Greater Than150 K0TotalCompGreaterThan150KInd
Compensation From Other Srcs0CompensationFromOtherSrcsInd
Cntrct Rcvd Greater Than100 K0CntrctRcvdGreaterThan100KCnt
All Other Contributions$67,317AllOtherContributionsAmt
Total Contributions$67,317TotalContributionsAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$6,986TotalRevenueColumnAmt
Exclusion$6,986ExclusionAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$74,303TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$6,986ExclusionAmt
FieldValueIRS element (for citing)
Info In Schedule O Part IXYes (X)InfoInScheduleOPartIXInd

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$626,701TotalAmt
Program Services$626,701ProgramServicesAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$58,750TotalAmt
Management And General$58,750ManagementAndGeneralAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$7,547TotalAmt
Management And General$7,547ManagementAndGeneralAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$2,899TotalAmt
Management And General$2,899ManagementAndGeneralAmt

Other Expenses OtherExpensesGrp

FieldValueIRS element (for citing)
DescTAXES AND LICENSESDesc
Total$25TotalAmt
Management And General$25ManagementAndGeneralAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$695,922TotalAmt
Program Services$626,701ProgramServicesAmt
Management And General$69,221ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$2,499,052BOYAmt
EOY$1,896,083EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$60,770BOYAmt
EOY$66,014EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

FieldValueIRS element (for citing)
BOY$791,500BOYAmt
EOY$1,153,500EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$3,351,322BOYAmt
EOY$3,115,597EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$16,925BOYAmt
EOY$35,575EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$16,925BOYAmt
EOY$35,575EOYAmt
FieldValueIRS element (for citing)
Organization Follows FASB117Yes (X)OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$3,334,397BOYAmt
EOY$3,080,022EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$3,334,397BOYAmt
EOY$3,080,022EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$3,351,322BOYAmt
EOY$3,115,597EOYAmt
FieldValueIRS element (for citing)
Info In Schedule O Part XIYes (X)InfoInScheduleOPartXIInd
Reconcilation Revenue Expnss-$621,619ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst$367,244NetUnrlzdGainsLossesInvstAmt
Other Changes In Net Assets$0OtherChangesInNetAssetsAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or Review0AccountantCompileOrReviewInd
FS AuditedYes (1)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Separate Basis Fincl StmtYes (X)SeparateBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit Committee0AuditCommitteeInd
Federal Grant Audit Required0FederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus3 Years$6,217,058CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$599,990CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$379,686CurrentTaxYearMinus1YearAmt
Current Tax Year$67,317CurrentTaxYearAmt
Total$7,264,051TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus3 Years$6,217,058CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$599,990CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$379,686CurrentTaxYearMinus1YearAmt
Current Tax Year$67,317CurrentTaxYearAmt
Total$7,264,051TotalAmt
FieldValueIRS element (for citing)
Substantial Contributors Tot$5,233,267SubstantialContributorsTotAmt
Public Support Total170$2,030,784PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus3 Years$14,642CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$61,051CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$49,600CurrentTaxYearMinus1YearAmt
Current Tax Year$6,986CurrentTaxYearAmt
Total$132,279TotalAmt
FieldValueIRS element (for citing)
Total Support$7,396,330TotalSupportAmt
First5 Years170Yes (X)First5Years170Ind

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule D IRS990ScheduleD

FieldValueIRS element (for citing)
Total Book Value Land Buildings$0TotalBookValueLandBuildingsAmt

Other Securities OtherSecuritiesGrp

FieldValueIRS element (for citing)
DescOTHER INVESTMENTSDesc
Book Value$1,153,500BookValueAmt
Method ValuationFMethodValuationCd
FieldValueIRS element (for citing)
Total Book Value Securities$1,153,500TotalBookValueSecuritiesAmt
Footnote TextYes (X)FootnoteTextInd
Total Rev Etc Audited Fincl Stmt$441,547TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst$367,244NetUnrealizedGainsInvstAmt
Revenue Not Reported$367,244RevenueNotReportedAmt
Revenue Subtotal$74,303RevenueSubtotalAmt
Revenue Not Reported Fincl Stmt$0RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990$74,303TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$695,922TotExpnsEtcAuditedFinclStmtAmt
Expenses Not Reported$0ExpensesNotReportedAmt
Expenses Subtotal$695,922ExpensesSubtotalAmt
Expenses Not Rpt Fincl Stmt$0ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990$695,922TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART X, LINE 2:FormAndLineReferenceDesc
ExplanationUNCERTAIN TAX POSITIONS THE FOUNDATION IS EXEMPT FROM FEDERAL INCOME TAX UNDER SECTION 501(C)(3). ACCOUNTING STANDARDS PRESCRIBE A RECOGNITION THRESHOLD AND MEASUREMENT ATTRIBUTE FOR THE FINANCIAL STATEMENT RECOGNITION AND MEASUREMENT OF A TAX POSITION TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN. THESE STANDARDS ALSO PROVIDE GUIDANCE ON DE-RECOGNITION OF TAX BENEFITS, CLASSIFICATION ON THE BALANCE SHEET, INTEREST AND PENALTIES, ACCOUNTING IN INTERIM PERIODS, DISCLOSURE, AND TRANSITION. THE FOUNDATION HAS EVALUATED ANY UNCERTAIN TAX POSITIONS AND RELATED INCOME TAX CONTINGENCIES AND DETERMINED UNCERTAIN POSITIONS, IF ANY, ARE NOT MATERIAL TO THE FINANCIAL STATEMENTS. PENALTIES AND INTEREST ASSESSED BY INCOME TAXING AUTHORITIES ARE INCLUDED IN OPERATING EXPENSES, IF INCURRED. TAX RETURNS ARE GENERALLY SUBJECT TO EXAMINATION BY FEDERAL AND STATE TAXING AUTHORITIES FOR THREE YEARS.ExplanationTxt

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Recipient Table RecipientTable (3 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdRecipient EINRecipientEINCash GrantCashGrantAmtNon Cash AssistanceNonCashAssistanceDescPurpose Of GrantPurposeOfGrantTxt
VANQUA BIO
711 DIMMEYDALE DRIVEDEERFIELDIL60015301205175$60,500N/ARESEARCH
CHAMISHI THERAPEUTICS INC
711 DIMMEYDALE DRIVEDEERFIELDIL60015352669722$375,001N/ARESEARCH
ASPEN NEUROSCIENCE INC
10835 ROAD TO THE CURESAN DIEGOCA92121831312969$191,200N/ARESEARCH
FieldValueIRS element (for citing)
Total Other Org3TotalOtherOrgCnt

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
SCHEDULE I, LINE 1THE SILVERSTEIN FOUNDATION FOR PARKINSON'S WITH GBA MAINTAINS RECORDS TO SUBSTANTIATE THE FUNDING AMOUNT, ELIGIBILITY CRITERIA AND SELECTION CRITERIA USED TO AWARD THE GRANTS. A GRANT CONTRACTING PROCESS SUMMARY PROVIDES DETAILED INSTRUCTIONS AND GUIDANCE FOR THE BOARD AND SCIENTIFIC ADVISORY BOARD (SAB) AS THEY SEEK NEW, CUTTING-EDGE THERAPEUTIC APPROACHES FOR TREATING AND PREVENTING PARKINSON'S DISEASE IN GBA MUTATION CARRIERS. THE SAB, WHICH GUIDES DECISION MAKING IN THE SELECTION PROCESS, IS COMPRISED OF ELEVEN (11) WORLD RENOWNED RESEARCHERS AND DRUG-DEVELOPERS. THEY ARE ABLE TO RAPIDLY COMB THROUGH GBA-RELATED RESEARCH TO ADVANCE OUR GOALS AND DETERMINE WHICH GRANTS SHALL BE AWARDED. THE GRANT CONTRACTING PROCESS OUTLINES THE STEPS THE FOUNDATION TAKES TO SUBSTANTIATE AMOUNTS AND ELIGIBILITY AS FOLLOWS; - PRIMARY INVESTIGATORS (PI'S) ARE ASKED TO SUBMIT A DETAILED RESEARCH PLAN AND COMPLETE MILESTONE AND BUDGET TEMPLATES WHICH ARE REVIEWED BY FOUNDATION STAFF AND SAB MEMBERS. - BUDGET JUSTIFICATION MAY BE REQUIRED. - FOR PRIVATE COMPANIES, HIGH-LEVEL FINANCIAL DOCUMENTS ARE REQUESTED IN ORDER TO PROVIDE CONFIRMATION THAT THE COMPANY HAS FINANCIAL STABILITY THROUGHOUT THE DURATION OF THE GRANT AND BEYOND. - ONCE ALL DOCUMENTS ARE RECEIVED FROM GRANTEE, INTERNAL REVIEW BY ALL SCIENTISTS ENSURES THAT ALL REQUESTS AND GOALS ARE APPROPRIATE. - A CONTRACT TEMPLATE, WHICH INCLUDES PAYMENT SCHEDULE, IS COMPLETED ONCE ALL DOCUMENTS HAVE BEEN VETTED BY INTERNAL STAFF. A PAYMENT SCHEDULE IS DETERMINED AND PAYMENTS ARE BASED UPON MILESTONES AND DELIVERABLES BEING MET. CLEAR GO/NO-GO POINTS FOR THE RESEARCH ARE REQUIRED. - FINAL EXECUTED CONTRACT, INCLUDING BUDGET AND MILESTONES ARE SIGNED BY THE FOUNDATION AND THE GRANTEE, AND ARE KEPT ON FILE. - FOUNDATION PERSONNEL ARE ASSIGNED TO OVERSEE THE PROGRESS OF THE GRANT, BOTH SCIENTIFICALLY AND ADMINISTRATIVELY. PROGRESS UPDATES, CHECK-INS AND REPORTING REQUIREMENTS ARE OUTLINED AND AGREED UPON IN THE CONTRACT AND ARE MONITORED CLOSELY BY PERSONNEL.
SCHEDULE I, LINE 2DESCRIBE THE FOUNDATION'S PROCEDURES FOR MONITORING THE USE OF GRANT FUNDS. THE SILVERSTEIN FOUNDATION FOR PARKINSON'S WITH GBA MAINTAINS A RIGOROUS GRANT MANAGEMENT PROCESS WHICH INVOLVES THE FOLLOWING STEPS: - IDENTIFY POINT OF CONTACT (POC) INTERNALLY AND COMMUNICATE THIS TO GRANTEE. - INFORM GRANTEE THAT THEY WILL BE IN TOUCH WITH POC PROACTIVELY ON: - FIRST MONTH PROGRESS ON RECRUITMENT AND HIRES (CLINICAL GRANT) - MONTHLY PROGRESS ON RECRUITMENT (CLINICAL GRANT) - SCHEDULING A THREE (3) MONTH CALL, MIDPOINT ASSESSMENT CALL AND FINAL ASSESSMENT MEETING/CALL. - SUBMIT MIDPOINT REPORT AND FINAL REPORT TO THE POC PROGRESS AGAINST MILESTONES. PAYMENTS WILL ONLY BE RELEASED IF MILESTONES ARE MET. - GRANTEE WILL NEED TO STAY IN TOUCH TO SHARE UPDATES. - ADJUST PAYMENTS IF MILESTONES ARE DELAYED. IF WORK CANNOT CONTINUE, MODIFICATION OF WORK OR EARLY TERMINATION OF GRANT WOULD BE REQUIRED. - UPON CONFIRMATION THAT PAYMENT CAN BE SENT, INFORM FOUNDATION TREASURER (NATALIE SILVERSTEIN) THREE (3) DAYS IN ADVANCE TO ISSUE PAYMENT. - SHARE GRANTEE NAME, AMOUNT AND BANK INFORMATION. TRACK INFORMATION IN GRANTS TRACKER, PAYMENT TAB. - DURING MIDPOINT AND FINAL REPORT SUBMISSION, ENSURE ALL HIGH-LEVEL DATA, FINDINGS AND RESULTS ARE SHARED IN WRITTEN FORM, EVEN IF GRANTEE PLANS TO SHARE INFORMATION VIA PHONE OR IN PERSON DURING ASSESSMENT MEETING. - FOUNDATION SHALL SAVE ALL REPORTS AND FINAL PRESENTATIONS IN GRANTEE'S FILE AS "REPORTS & RESULTS".

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (6 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
FORM 990, PART III, LINE 1, ORGANIZATION'S MISSIONCONTINUE FROM PART III: WE AGGRESSIVELY SEEK OUT NEW CUTTING EDGE THERAPEUTIC APPROACHES TO TREATING AND PREVENTING PARKINSON'S IN GBA MUTATION CARRIERS. THROUGH CLINICIANS, SCIENTISTS AND BIOTECH COMPANIES, WE SEEK TO ACCELERATE RESEARCH AND CLINICAL TRIALS IN AN EFFORT TO RAPIDLY BRING NEW THERAPEUTIC OPTIONS TO PATIENTS.
FORM 990, PART III, LINE 4A, PROGRAM SERVICESCONTINUE FROM PART III: THE FOUNDATION PREVIOUSLY FUNDED THE FOLLOWING INITIATIVES THAT CONTINUE TO ADVANCE THE MISSION OF THE ORGANIZATION: - PREVAIL THERAPEUTICS, A COMPANY THAT THE FOUNDATION STARTED WITH ASA ABELIOVICH, RAISED $200 MILLION VIA PRIVATE AND PUBLIC FINANCING. PREVAIL RECENTLY ANNOUNCED THAT ENROLLMENT IN THE PR001 PHASE 1/2 PROPEL CLINICAL TRIAL IS PROGRESSING, PATIENT DOSING CONTINUES, AND THE COMPANY IS HOPEFUL THAT IT WILL REMAIN ON TRACK TO REPORT INTERIM DATA ON A SUBSET OF PATIENTS IN THE SECOND HALF OF 2020. - ASPEN NEUROSCIENCE, WHICH WAS SPUN OUT OF SCRIPPS INSTITUTE AND THE LAB OF WORLD-RENOWNED STEM CELL RESEARCHER DR. JEAN LORING, RAISED MORE THAN $70 MILLION TO STUDY AUTOLOGOUS STEM CELL APPROACHES. VANQUA BIO WAS LAUNCHED IN 2019 BASED ON FOUNDATION-FUNDED RESEARCH BEING CONDUCTED IN THE LABORATORY OF DR. DIMITRI KRAINC AT NORTHWESTERN UNIVERSITY. THE COMPANY IS FOCUSED ON DEVELOPING SMALL MOLECULE MODULATORS OF LYSOSOMAL TARGETS THAT HAVE GENETIC LINKAGES TO GBA PD. TOGETHER WITH Q-STATE BIOSCIENCES, THE FOUNDATION LAUNCHED CHAMISHI THERAPEUTICS, A NEW DRUG DISCOVERY AND DEVELOPMENT COMPANY FOCUSED ON NEURODEGENERATIVE DISEASES AND OTHER RELATED DISORDERS. THE PARTNERSHIP WILL COMBINE THE SILVERSTEIN FOUNDATION'S DEEP SCIENTIFIC KNOWLEDGE BASE WITH Q-STATE'S PRECISION MEDICINE PLATFORM, DISEASE-RELEVANT CELLULAR ASSAYS, AND ASO (ANTISENSE-OLIGONUCLEOTIDE) DESIGN CAPABILITIES. CHAMISHI IS LED BY JIM SULLIVAN, FORMER VICE PRESIDENT OF PHARMACEUTICAL DISCOVERY AT ABBVIE. IN 2020, VANQUA BIO RECEIVED TWO ADDITIONAL GRANTS IN SUPPORT OF ITS RESEARCH DEVELOPING SMALL MOLECULE MODULATORS OF LYSOSOMAL TARGETS THAT HAVE GENETIC LINKAGES TO GBA PD. PREVAIL THERAPEUTICS, WHICH WAS CO-FOUNDED BY THE SILVERSTEIN FOUNDATION IN 2019, WAS ACQUIRED BY ELI LILLY AND COMPANY IN DECEMBER 2020.
FORM 990, PART VI, SECTION A, LINE 2DIRECTORS JONATHAN SILVERSTEIN AND NATALIE SILVERSTEIN HAVE A FAMILY RELATIONSHIP.
FORM 990, PART VI, SECTION B, LINE 11BTHE FORM 990 IS PREPARED, USING INFORMATION PROVIDED BY THE FOUNDATION, BY AN INDEPENDENT ACCOUNTING FIRM. THE 990, AS WILL BE FILED WITH THE IRS, IS REVIEWED BY THE BOARD PRIOR TO ITS FILING WITH THE INTERNAL REVENUE SERVICE.
FORM 990, PART VI, SECTION B, LINE 12CTHE FOUNDATION HAS A CONFLICT OF INTEREST POLICY IN PLACE. (A) IF THE FOUNDATION HAS MULTIPLE DIRECTORS, A DIRECTOR WHO IS DIRECTLY OR INDIRECTLY A PARTY TO A TRANSCATION WITH THE FOUNDATION (AN "INTERESTED DIRECTOR") SHALL DISCLOSE THE MATERIAL FACTS OF THE TRANSACTION AND HIS OR HER INTEREST IN OR RELATIONSHIP TO SUCH TRANSACTION TO THE BOARD OF DIRECTORS AND TO ANY COMMITTEE OF THE BOARD CONSIDERING SUCH TRANSACTION PRIOR TO ANY ACTION BY THE BOARD OR SUCH COMMITTEE TO AUTHORIZE, APPROVE OR RATIFY SUCH TRANSACTION. A DIRECTOR IS "INDIRECTLY" A PARTY TO A TRANSACTION IF THE ENTITY WHICH IS A PARTY IS AN ENTITY IN WHICH THE DIRECTOR HAS A MATERIAL FINANCIAL INTEREST OR OF WHICH THE DIRECTOR IS AN OFFICER, DIRECTOR OR GENERAL PARTNER. (B) THE TRANSACTION SHALL BE APPROVED IN GOOD FAITH BY THE BOARD OF DIRECTORS OR A COMMITTEE OF THE BOARD BY THE AFFIRMATIVE VOTE OF: (I) A MAJORITY OF THE DISINTERESTED DIRECTORS; OR (II) A MAJORITY OF ALL THE DIRECTORS ON THE BOARD OR COMMITTEE AFTER DECIDING THAT THE TRANSACTION IS FAIR TO THE FOUNDATION AS OF THE TIME IT IS AUTHORIZED BY THE BOARD OR COMMITTEE. THE PRESENCE OF AN INTERESTED DIRECTOR OR OF A DIRECTOR WHO IS OTHERWISE NOT DISINTERESTED MAY BE COUNTED IN DETERMINING WHETHER A QUORUM OF THE BOARD OF DIRECTORS OR A COMMITTEE OF THE BOARD IS PRESENT. THE BOARD OF DIRECTORS MAY IN ITS DISCRETION ADOPT OTHER PROCEDURES AS THE BOARD DETERMINES IS APPROPRIATE TO ADDRESS CONFLICTS OF INTEREST.
FORM 990, PART VI, SECTION C, LINE 19DOCUMENTS ARE AVAILABLE UPON REQUEST.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.